CA
RETA
Corriente Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-71,115
| Closed | -$10.1M | – | 20 |
|
|
2021
Q2 | $10.1M | Buy |
+71,115
| New | +$10.1M | 5.43% | 5 |
|
|
2021
Q1 | – | Sell |
-525,000
| Closed | -$64.9M | – | 19 |
|
|
2020
Q4 | $64.9M | Buy |
525,000
+225,000
| +75% | +$27.8M | 15.45% | 2 |
|
|
2020
Q3 | $29.2M | Buy |
300,000
+152,500
| +103% | +$14.9M | 14.82% | 2 |
|
|
2020
Q2 | $23M | Sell |
147,500
-42,500
| -22% | -$6.63M | 14.91% | 2 |
|
|
2020
Q1 | $27.4M | Sell |
190,000
-2,000
| -1% | -$289K | 29.6% | 1 |
|
|
2019
Q4 | $39.3M | Buy |
+192,000
| New | +$39.3M | 21.08% | 2 |
|